EUVIMEDEUVIMED entdecken
Crossref

Disease modeling using human induced pluripotent stem cell-derived microglia and region-specific neurons

Kaneyasu Nishimura, Kazuyuki Takata

Folia Pharmacologica Japonica · 2023

DOI: 10.1254/fpj.22087 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Folia Pharmacologica Japonica, 2023. Verfasst von Kaneyasu Nishimura und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University. Hauptthemen laut MEDLINE: Induced Pluripotent Stem Cells, Neurodegenerative Diseases, Alzheimer Disease, Parkinson Disease. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 26 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Neurodegenerative disorders including Alzheimer's disease (AD) and Parkinson's disease (PD) are hard to treat once they have suffered. Therefore, the establishment of new prevention and treatment methods for neurodegenerative disorders is an urgent issue for Japan's aging society, from the perspective of improving the quality of life of patients and medical staff involved in their care. Human induced pluripotent stem cells (hiPSCs) have contributed to the understanding of the pathology of neurodegenerative diseases, and to the development of new preventive and therapeutic strategies based on the understanding of human diseases. Furthermore, new cross-disciplinary scientific trends together with iPSC technology are emerging in the fields of life science, medical science, and information technology. The fusion of various research knowledges and technologies may provide new scientific progress for better understanding of molecular mechanisms of pathology and the onset of neurodegenerative diseases. Here we have developed new brain model with hiPSC technology for the understanding of pathology of AD and PD based on the induction of region-specific brain organoids and microglia using hiPSCs. These brain organoids technology enables us to provide simpler and reproducible analytical methods by combining with not only developmental biology and pharmacology but also transcriptome analysis and direct conversion. These technological advantages contribute to the creation of new research fields with human brain research to understand higher brain functions and pathophysiology of neurodegenerative diseases such as AD and PD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Induced Pluripotent Stem CellsNeurodegenerative DiseasesAlzheimer DiseaseParkinson DiseaseHumansMicrogliaQuality of LifeNeurons

Autor:innen und Institutionen

  • Division of Integrated Pharmaceutical Sciences, Kyoto Pharmaceutical University.
  • Laboratory of Functional Brain Circuit Construction, Graduate School of Brain Science, Doshisha University.

Zitieren

APA

Nishimura, K., & Takata, K. (2023). Disease modeling using human induced pluripotent stem cell-derived microglia and region-specific neurons. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.22087

Vancouver

Nishimura K, Takata K. Disease modeling using human induced pluripotent stem cell-derived microglia and region-specific neurons. Folia Pharmacologica Japonica. 2023. doi:10.1254/fpj.22087

BibTeX
@article{Nishimura2023,
  author = {Nishimura, Kaneyasu and Takata, Kazuyuki},
  title = {Disease modeling using human induced pluripotent stem cell-derived microglia and region-specific neurons},
  journal = {Folia Pharmacologica Japonica},
  year = {2023},
  doi = {10.1254/fpj.22087}
}
Kostenlos starten →